Table 1 Baseline characteristics of the study group (N = 300).
Feature | Number | |
|---|---|---|
Age | Range | 5 days–12 months |
Median (IQR) (months) | 4 (2; 8) | |
Sex | Male/female | 169 (56)/131 (44) |
Household contact with an infected family member | Yes | 177 (59) |
Confirmed other contact | Yes | 2 (1) |
Confirmed COVID-19 in a family member (data available for 173 patients) | Before the diagnosis established in the child | 54 (31) |
Diagnosis in the child established simultaneously | 99 (57) | |
After the diagnosis established in the child | 20 (12) | |
Duration to negative PCR testing for SARS-CoV-2 infection (data available for 28 patients) | Days, median (IQR) | 18 (11; 21) |
Hospitalization | Yes | 282 (94) |
Lasting one-day | 46 (15) | |
Lasting over 24 h | 236 (79) | |
Duration (days), Median (IQR) | 5 (3; 8) | |
Duration of infection before admission | Days Median (IQR) | 2 (1; 3) |
International travel | (During 14 days before the onset of the disease) | 6 (2) |
Comorbidities including | Present | 35 (12) |
Congenital disabilities | 7 | |
Epilepsy | 4 | |
Prematurity | 3 | |
Atopic dermatitis | 3 | |
Bronchopulmonary dysplasia | 3 | |
Immunodeficiency | 1 | |
Wave of COVID-19 pandemic | (1st/2nd) | 49 (16)/251 (84) |
